Calcium channel drugs and uses
View Patent ↗Novel multibinding compounds are disclosed. The compounds of this invention comprise 2-10 ligands covalently connected, each of the ligands being capable of binding to a ligand binding site in a Ca ++ channel , thereby modulating the biological activities thereof.
1. A compound of the formula:
L-X-L
or a pharmaceutically-acceptable salt thereof;
wherein one L is a ligand of formula (vi):
and the other L is a ligand independently selected from the group consisting of formula (i), (ii), (iii), (iv), (v) and (vi):
and
X is a linker of the formula:
—X′-Z-(Y′-Z) m -Y″-Z-X′—
in which:
m is an integer from 0 to 20;
X′ at each separate occurrence is —O—, —S—, —S(O)—, —S(O)2-, —NR—, —NRR′, —C(O)—, —C(O)O—, —C(O)NH—, —C(S)—, —C(S)O—, —C(S)NH— or a covalent bond, where R and R′ at each separate occurrence are as defined below for R′ and R″;
Z is at each separate occurrence selected from alkylene, substituted alkylene, alkylalkoxy, cycloalkylene, substituted cycloalkylene, alkenylene, substituted alkenylene, alkynylene, substituted alkynylene, cycloalkenylene, substituted cycloalkenylene, arylene, substituted arylene, heteroarylene, heterocyclene, substituted heterocyclene, crown compounds or a covalent bond;
Y′ and Y″ at each separate occurrence are selected from —S—S—, a covalent bond or a structure selected from the following group:
in which:
n is 0, 1 or 2; and
R′ and R″ at each separate occurrence are selected from hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, heteroaryl or heterocyclic.
2. The compound according to claim 1 , wherein the compound is of the following structure:
3. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a compound of claim 1 or 2 .